Latest Stock Buy or Sell? Make More Informed Decisions!
Today, The Panic-Proof Portfolio (Stockchase Research) and David Baskin commented about whether CPRT-Q, GRT.UN-T, NA-T, CVS-N, SAP-T, CP-T, CGX-T, PKI-T, FFH-T, TFII-T, SHOP-T, CCO-T, T-N, VZ-N, BAM-N, LYV-N, QSR-T, BNS-T, BAM-N, BN-T, BNRE-T, ENB-T, POW-T, NVDA-Q, XOM-N, DOL-T, NVO-N, FND-N, HD-N, MX-T, ING-N, EPD-N, MRD-T are stocks to buy or sell.
- Page 1/3
- Next Page
We reiterate EPD as a TOP PICK. Cash flow per unit is growing by 15%, while debt is aggressively retired. It has over $6 billion in project back logs. Its excellent dividend is backed by a payout ratio under 80% of cash flow. We continue to recommend a stop at $24, looking to achieve $32 -- upside potential of 20%. Yield 7.6%
(Analysts’ price target is $31.84)With recently reported earnings showing income up 32% over the year, we reiterate ING as a TOP PICK. It trades at 8x earnings, under book value and supports a ROE of 29%. Its dividend is backed by a payout ratio under 35% of cash flow. It added over 11 billion euros in new deposits and their customer base continue to grow. We continue to recommend a stop at $12.50, with upside to $19.00 -- potential of 38%. Yield 4.3%
(Analysts’ price target is $19.14)We might have recession in Canada, not the US. The Bank of Canada has gone too far. Canadians are too indebted and too many have variable rate mortgages. So consumers will spend less. It will be a mild recession. Canada imports so much food and doesn't control energy costs, so we can't control that much inflation. But savers will do well, given these high rates. Seniors, who rely on fixed income, will collect 5% interest. The US will pull off a soft landing.
The largest company in Scandinavia. There is and will be lots of competition in weight-loss drugs. NVO has made a fortune through this drug, but their margins will shrink over time as competitors come. If you own this already, take profits, but don't expect NVO to double again.
It went ex-dividend today so shares declined and will rise until the next dividend date. This shouldn't determine whether you buy a stock or not. It yields near 8%. Some don't like their heavy debt and prefer collecting a safe 6% bond. But once bonds pay lower, like 4%, then shares like this pop up and ENB will hit $50 in a heartbeat.
Unfortunately, Brookfield is looking like the old Brascan empire, a plate of spaghetti, where they spin off all these entities, then buy them back and it's hard to keep track of how many there are. That said, BAM and BN-T are grossly undervalued. The market is overreacting to the impact of commercial real estate BN-T, in particular. Do the swap.
Unfortunately, Brookfield is looking like the old Brascan empire, a plate of spaghetti, where they spin off all these entities, then buy them back and it's hard to keep track of how many there are. That said, BAM and BN-T are grossly undervalued. The market is overreacting to the impact of commercial real estate BN-T, in particular.
We reiterate MRD as a TOP PICK. Despite a challenging environment with inflation and high interest rates, the company is seeing good development in the Calgary marketplace and in Colorado. Recent quarterly earnings showed cash reserves growing once again, with debt being retired and shares bought back. It trades at 5x earnings and under book value. The dividend is covered by a payout ratio under 25% of cash flow. We continue to recommend a stop at $10.75, looking to achieve $14.00 -- upside potential of 21%. Yield 5.4%
(Analysts’ price target is $14.00)